Karydas Daphne

Director at MLYS

Sold, on record
$926k
Dollars the filings state
Form 4 sales
4
Latest Sep 15, 2026
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • MLYSMineralys Therapeutics, Inc.Director

Sales by reason

3
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale MLYSUnusual
    Nov 13, 2025 2025

    Sold 15,000 shares at $45.99 ($690k)

    Karydas Daphne, Director

    No 10b5-1 planSold 100% of holdings ($690k position)0 shares leftFirst sale on recordFiling

  2. 2 Form 4 sale MLYSRoutine
    Mar 31, 2026 +138 days

    Sold 3,000 shares at $25.00 ($75k)

    Karydas Daphne, Director

    10b5-1 planSold 32.6% of holdings ($230k position)6,200 shares leftFiling

  3. 3 Form 4 sale MLYSRoutine
    Jun 17, 2026 +78 days

    Sold 3,000 shares at $25.00 ($75k)

    Karydas Daphne, Director

    10b5-1 planSold 32.6% of holdings ($230k position)6,200 shares leftFiling

  4. 4 Form 4 sale MLYSRoutine
    Sep 15, 2026 +90 days

    Sold 3,000 shares at $28.58 ($86k)

    Karydas Daphne, Director

    10b5-1 planSold 32.6% of holdings ($263k position)6,200 shares left1x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (4)

Form 144 notices and Form 4 sales by Karydas Daphne
Source
Sep 15, 2026Sep 17, 2026MLYSDirectorForm 4 sale3,000$86k32.6%RoutineSEC
Jun 17, 2026Jun 17, 2026MLYSDirectorForm 4 sale3,000$75k32.6%RoutineSEC
Mar 31, 2026Apr 2, 2026MLYSDirectorForm 4 sale3,000$75k32.6%RoutineSEC
Nov 13, 2025Nov 13, 2025MLYSDirectorForm 4 sale15,000$690k100.0%UnusualSEC